Better ways to use continuous glucose monitors for hospitalized adults with diabetes
Developing statistical analysis and prediction tools for continuous glucose monitoring (CGM) use in hospitalized patients with diabetes
This project will create computer tools that turn hospital continuous glucose monitor readings into clear, usable guidance for adults with diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11291848 on NIH RePORTER |
What this research studies
You would be helped if you are an adult with diabetes who needs glucose monitoring while in the hospital. The team will analyze continuous glucose monitor (CGM) data from multiple hospitals to build statistical and prediction tools that handle gaps, noise, and interruptions common in inpatient settings. They will train models to flag likely dangerous high or low glucose patterns and to summarize complex CGM trends for clinicians. The methods aim to support more personalized, real-time glucose decisions by hospital care teams.
Who could benefit from this research
Good fit: Adults with diabetes who are hospitalized and either already using or eligible for continuous glucose monitoring are the ideal candidates for this work.
Not a fit: People without diabetes, children under 21, or hospitalized patients who cannot wear CGM sensors (for example due to skin problems or certain critical-care situations) are unlikely to benefit directly.
Why it matters
Potential benefit: If successful, these tools could help hospital teams detect dangerous high or low glucose faster, personalize glucose management, and reduce complications and length of stay.
How similar studies have performed: Previous clinical studies have shown inpatient CGM can be safe and useful, but developing tailored statistical and prediction tools for hospital CGM data is largely new.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Peng, Limin — Emory University
- Study coordinator: Peng, Limin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.